Geode Capital Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-127,650
| Closed | -$663K | – | 4152 |
|
|
2016
Q4 | $663K | Buy |
127,650
+352
| +0.3% | +$1.66K | ﹤0.01% | 3173 |
|
|
2016
Q3 | $594K | Buy |
127,298
+88
| +0.1% | +$411 | ﹤0.01% | 3186 |
|
|
2016
Q2 | $501K | Sell |
127,210
-2,487
| -2% | -$9.29K | ﹤0.01% | 3224 |
|
|
2016
Q1 | $401 | Sell |
129,697
-20,847
| -14% | -$69.8K | ﹤0.01% | 3339 |
|
|
2015
Q4 | $687K | Buy |
150,544
+23,073
| +18% | +$109K | ﹤0.01% | 3103 |
|
|
2015
Q3 | $600K | Sell |
127,471
-3,356
| -3% | -$21.7K | ﹤0.01% | 3136 |
|
|
2015
Q2 | $936K | Sell |
130,827
-4,685
| -3% | -$35.2K | ﹤0.01% | 2927 |
|
|
2015
Q1 | $1.15M | Buy |
135,512
+7,008
| +5% | +$59.7K | ﹤0.01% | 2796 |
|
|
2014
Q4 | $1.2M | Buy |
128,504
+2,608
| +2% | +$22.7K | ﹤0.01% | 2737 |
|
|
2014
Q3 | $1.05M | Buy |
125,896
+1,754
| +1% | +$16.2K | ﹤0.01% | 2749 |
|
|
2014
Q2 | $1.44M | Buy |
124,142
+2,504
| +2% | +$25.7K | ﹤0.01% | 2577 |
|
|
2014
Q1 | $1.54M | Buy |
121,638
+66,288
| +120% | +$857K | ﹤0.01% | 2500 |
|
|
2013
Q4 | $598K | Buy |
55,350
+537
| +1% | +$6.24K | ﹤0.01% | 3000 |
|
|
2013
Q3 | $679K | Buy |
54,813
+1,703
| +3% | +$23.6K | ﹤0.01% | 2799 |
|
|
2013
Q2 | $709K | Buy |
+53,110
| New | +$683K | ﹤0.01% | 2664 |
|
Other funds holding DSCI
Geode Capital Management's DSCI Position: Q1 2017 in Review
Geode Capital Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 127,650 shares — an estimated $663K sold.
Geode Capital Management first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $1.54M in Q1 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.
- Geode Capital Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
- Geode Capital Management sold 127,650 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $663K.
- Geode Capital Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 15 quarters.
- Geode Capital Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $1.54M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.
Based on Geode Capital Management's 13F filing for Q1 2017, filed 12 May 2017.